Safety and Toxicokinetics of Intravenous Liposomal Amphotericin B (AmBisome ®) in Beagle Dogs

Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Robert W. Finberg, Carola Arndt et al. · New England Journal of Medicine · 1999 · 1.2K citations · Full text

Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

G. Lopez‐Berestein, Victor Fainstein, Roy L. Hopfer et al. · The Journal of Infectious Diseases · 1985 · 408 citations

Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B

Gabriel Lopez‐Berestein, R T Mehta, Roy L. Hopfer et al. · The Journal of Infectious Diseases · 1983 · 301 citations

Immunology, Pharmacotherapy, Antimicrobial Chemotherapy +16

Development, Characterization, Efficacy and Mode of Action of Ambisome, A Unilamellar Liposomal Formulation of Amphotericin B

Jill Adler‐Moore, Richard T. Proffitt · Journal of Liposome Research · 1993 · 245 citations

Lipid Preparation, Medicinal Chemistry, Pharmaceutical Science +10

Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents

Richard T. Proffitt, A. Satorius, S.-M. Chiang et al. · Journal of Antimicrobial Chemotherapy · 1991 · 202 citations